| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 24 |
| 1 | OXALIPLATIN | 23 |
| 2 | FLUOROURACIL | 22 |
| 3 | FLUOROURACIL CREAM, 0.5% | 22 |
| 4 | APIXABAN | 20 |
| 5 | METFORMIN | 20 |
| 6 | INSULIN GLARGINE | 19 |
| 7 | PREDNISONE | 19 |
| 8 | METFORMIN ER 500 MG | 18 |
| 9 | METFORMIN ER 750 MG | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEGFILGRASTIM-APGF | 2 | 0.0101 |
| 1 | REGORAFENIB | 8 | 0.0007 |
| 2 | BARICITINIB | 2 | 0.0007 |
| 3 | IRINOTECAN HYDROCHLORIDE | 7 | 0.0005 |
| 4 | EFGARTIGIMOD ALFA | 2 | 0.0005 |
| 5 | APREPITANT | 3 | 0.0004 |
| 6 | ERGOCALCIFEROL | 11 | 0.0004 |
| 7 | CLINDAMYCIN PHOSPHATE | 2 | 0.0004 |
| 8 | PANITUMUMAB | 5 | 0.0003 |
| 9 | LEUCOVORIN CALCIUM | 6 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 37 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 36 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 34 |
| 3 | Factor Xa Inhibitor [EPC] | 33 |
| 4 | Insulin Analog [EPC] | 26 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 25 |
| 6 | Platinum-based Drug [EPC] | 24 |
| 7 | Benzodiazepine [EPC] | 20 |
| 8 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 18 |
| 9 | GLP-1 Receptor Agonist [EPC] | 17 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 2 | Neonatal Fc Receptor Blocker [EPC] | 2 | 0.0005 |
| 3 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 4 | Provitamin D2 Compound [EPC] | 11 | 0.0004 |
| 5 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 3 | 0.0003 |
| 6 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 2 | 0.0003 |
| 7 | Thrombopoietin Receptor Agonist [EPC] | 3 | 0.0002 |
| 8 | Antimetabolite Immunosuppressant [EPC] | 4 | 0.0002 |
| 9 | Non-Standardized Insect Allergenic Extract [EPC] | 1 | 0.0002 |